Lpl Financial LLC Sesen Bio, Inc. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.49 - $0.61 $490 - $610	-1,000 Reduced 7.91%	11,650 $7,000
Q3 2022 Nov 14, 2022	SELL	$0.0 - $0.93 $0 - $19,530	-21,000 Reduced 62.41%	12,650 $5,000
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.89 $1,178 - $2,759	3,100 Added 10.15%	33,650 $27,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $580 - $860	-1,000 Reduced 3.17%	30,550 $18,000
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $9,088 - $15,936	-12,450 Reduced 28.3%	31,550 $26,000
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $11,049 - $70,458	14,350 Added 48.4%	44,000 $35,000
Q2 2021 Aug 13, 2021	BUY	$2.18 - $4.66 $24,743 - $52,891	11,350 Added 62.02%	29,650 $137,000
Q1 2021 May 14, 2021	BUY	$1.3 - $3.24 $23,790 - $59,292	18,300 New	18,300 $48,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.